Bala Bhagavath

Bala Bhagavath

Auto-generated profile, based on publicly available information

Bala Bhagavath

Women's Health Research Collaborative, New York, NY, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Fertility and Sterility
Verified
Journal Article
Closed access
ALArtur Ludwin
Artur Ludwin
SLSteven R. Lindheim
Steven R. Lindheim
BBBala Bhagavath
Bala Bhagavath
WMWellington P. Martins
Wellington P. Martins
ILInga Ludwin
Inga Ludwin

7 September 2025 in Human Reproduction Update
Verified
Journal Article
Open access
MMMalcolm G Munro
Malcolm G Munro
CSChristina A Salazar
Christina A Salazar
BBBala Bhagavath
Bala Bhagavath
MEMark H Emanuel
Mark H Emanuel
HHHeather G Huddleston
Heather G Huddleston
WGWomen's Health Research Collaborative's Endometrial Trauma Group
Women's Health Research Collaborative's Endometrial Trauma Group
BACKGROUND: Reproductive-age women with intrauterine adhesions (IUAs) following uterine surgery may be asymptomatic or may experience light or absent menstruation, infertility, preterm delivery, and/or peripartum hemorrhage. Understanding procedure- and technique-specific risks and the available evidence on the impact of surgical adjuvants is essential to the design of future research. OBJECTIVE AND RATIONALE: While many systematic reviews have been published, most deal with singular aspects of the problem. Consequently, a broadly scoped systematic review and selective meta-analyses identifying evidence strengths and gaps are necessary to inform future research and treatment strategies. SEARCH METHODS: A systematic literature review was performed seeking evidence on IUA incidence following selected uterine procedures and the effectiveness of hysteroscopic adhesiolysis on menstrual, endometrial, fertility, and pregnancy-related outcomes. An evaluation of the impact of surgical adjuvants designed to facilitate adhesion-free endometrial repair was included. Searches were conducted in the PubMed, Embase, and Cochrane databases following PRISMA guidelines and included English-language publications from inception to 8 November 2024. Inclusion criteria restricted articles to those reporting IUA epidemiology or related clinical outcomes. Risk of bias assessment used the US NIH tools for interventional and observational studies. Meta-analyses were conducted and reported only for outcomes where there were sufficient data. Per analysis, we report on proportions (with 95% CI), heterogeneity (I2), and the risk of bias for each study included. OUTCOMES: The review identified 249 appropriate publications. The risks of new-onset IUAs following the removal of products of conception after early pregnancy loss, hysteroscopic myomectomy, and hysteroscopic metroplasty for septum correction were 17% (95% CI: 11–25%; 13 studies, I2 = 87%, poor to good evidence quality), 16% (95% CI: 6–28%; 8 studies, I2 = 93%, fair to good evidence quality), and 28% (95% CI: 13–46%; 8 studies, I2 = 91%, fair to good evidence quality), respectively. For primary IUA prevention with adjuvant intrauterine gel barriers, the relative risks were 0.45 (95% CI: 0.30–0.68; three studies, I2 = 0%, poor to good evidence quality), 0.38 (95% CI: 0.20–0.73; three studies, I2 = 0%, fair evidence quality), and 0.29 (95% CI: 0.12–0.69; three studies, I2 = 0%, fair to good evidence quality), respectively, following the above potentially adhesiogenic procedures. Following adhesiolysis without adjuvants, the IUA recurrence rate was 35% (95% CI: 24–46%; 13 studies, I2 = 95%, poor to good evidence quality), similar to the rate of 43% for both those treated adjuvantly with an intrauterine balloon (95% CI: 35–51%; 14 studies, I2 = 85%, poor to good evidence quality), or an IUD (95% CI: 27–59%; four studies, I2 = 85%, fair to good evidence quality). The recurrence rate for secondary prevention with gel barriers was 28% (95% CI: 4–62%; three studies, I2 = 94%, good evidence quality). Notably, there was an excess rate of associated adverse obstetrical outcomes, including preterm delivery, placenta accreta spectrum, placenta previa, peripartum hemorrhage, and hysterectomy, with evidence demonstrating the beneficial impact of adjuvant therapies on these outcomes. WIDER IMPLICATIONS: This systematic review comprehensively analyzes IUA formation following uterine surgical procedures and adjuvant therapy effectiveness. Even following adhesiolysis, it is apparent that the basilar endometrial trauma thought to facilitate the formation of IUAs may persist and contribute to adverse reproductive outcomes. Many critical gaps remain in our knowledge of the pathogenesis, prevention, and management of endometrial trauma and IUAs. PREGISTRATION NUMBER: PROSPERO (ID: CRD42023366218).

1 May 2021 in Fertility and Sterility
Verified
Journal Article
Closed access
BBBala Bhagavath
Bala Bhagavath
SLSteven R. Lindheim
Steven R. Lindheim

13 October 2020 in Fertility and Sterility
Verified
Journal Article
Closed access
PDF file
BBBala Bhagavath
Bala Bhagavath
ALArtur Ludwin
Artur Ludwin
SLSteven R. Lindheim
Steven R. Lindheim

1 January 2021 in Fertility and Sterility
Verified
Journal Article
Closed access
BBBala Bhagavath
Bala Bhagavath
LGLinnea Goodman
Linnea Goodman
JPJohn Petrozza
John Petrozza

1 August 2022 in Current Opinion in Obstetrics and Gynecology
Verified
Journal Article
Closed access
BBBala Bhagavath
Bala Bhagavath
Purpose of review: The last decade has witnessed a radical change in the field of reproductive surgery. The increasing success of in-vitro fertilization (IVF) has caused a huge shift in emphasis with many downstream consequences. This review outlines the changes and provides insight into the future of reproductive surgery. Recent findings: With compelling evidence that IVF overcomes the detrimental effects of endometriosis on infertility and with two new oral medications available for management of endometriosis, momentum is shifting towards nonsurgical management of endometriosis. There is increasing recognition that except for submucous myomas, other myomas are unlikely to affect fertility and miscarriage. This, in addition to many emerging alternative modalities for management of myomas (oral GnRH antagonists, radiofrequency ablation), is likely to further decrease classic myomectomies but provide alternative, less invasive options. Caesarean scar defects have been recognized as having significant reproductive consequences and surgical management has become the standard of care. Fallopian tubes are now implicated in development of ovarian cancer, and as a result, salpingectomies are being performed in lieu of tubal ligations. Tubal anastomosis will soon become a historical surgery. Division of uterine septum remains controversial, and a clear answer will remain elusive. Uterine transplant is the single most significant advance in reproductive surgery in the past century. Summary: Reproductive surgery is evolving with the times. Although some surgical techniques will become historical, others will become mainstream.